rAAV-based compositions and methods
US10077452B2 · kind B2 · utility
17Cited by
20References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2016 |
| Grant date | Sep 18, 2018 |
| Priority date | — |
| Expiry date | Apr 14, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to isolated nucleic acids and rAAV-based compositions, methods and kits useful for treating genetic diseases (e.g., alpha-1 antitrypsin deficiency).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.